OmniBRx Biotechnologies: Funding, Investors & Team (Oct 2026)
Omnibrx Biotechnologies have created a versatile solution for efficient and simple adherent cell culture processing that is easily scalable. This system consists of single-use bioreactors with a new design that is easy to implement and use quickly. The CellBRx bioreactors technology uses a compact rotating dynamic-bed design with specialized disc-shaped macro-carriers. These macro-carriers are made of medical-grade non-woven polyester microfibers that meet USP Class VI and ISO 10993 certification standards and come in sizes ranging from 0.25L to 1000L working volume.
OmniBRx Biotechnologies has raised $3.6M across 1 funding round on record, the most recent a Series A of $3.6M announced in Mar 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OmniBRx Biotechnologies Company Profile and Key Stats
Latest funding round on record: Mar 2023.
OmniBRx Biotechnologies Funding Rounds
OmniBRx Biotechnologies Founders and Leadership Team
Contact details for the OmniBRx Biotechnologies team: 1 of 1 has an email address on file.
Start 14-day free trial →OmniBRx Biotechnologies Funding Compared to Other Biotechnology Startups
OmniBRx Biotechnologies' latest round of $3.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OmniBRx Biotechnologies in Biotechnology and Ahmedabad
Companies Similar to OmniBRx Biotechnologies
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
BrainSightAI is a software platform that uses MRI technology to improve accuracy in neurological and…
OmniBRx Biotechnologies Funding FAQs
What does OmniBRx Biotechnologies do?
Omnibrx Biotechnologies have created a versatile solution for efficient and simple adherent cell culture processing that is easily scalable. This system consists of single-use bioreactors with a new design that is easy to implement and use quickly. The CellBRx bioreactors technology uses a compact rotating dynamic-bed design with specialized disc-shaped macro-carriers. These macro-carriers are made of medical-grade non-woven polyester microfibers that meet USP Class VI and ISO 10993 certification standards and come in sizes ranging from 0.25L to 1000L working volume.
How much funding has OmniBRx Biotechnologies raised?
OmniBRx Biotechnologies has raised $3.6M across 1 round on record. The most recent is a Series A of $3.6M announced in Mar 2023.
When did OmniBRx Biotechnologies last raise funding?
OmniBRx Biotechnologies' most recent funding round on record is a Series A of $3.6M, announced in Mar 2023.
Who founded OmniBRx Biotechnologies?
FundedIQ lists Ravindra Patel (Founder) at OmniBRx Biotechnologies.
Where is OmniBRx Biotechnologies headquartered?
OmniBRx Biotechnologies is based in Ahmedabad, Gujarat, India.
How many employees does OmniBRx Biotechnologies have?
OmniBRx Biotechnologies is in the 11-50 employee band.
How does OmniBRx Biotechnologies' funding compare to other Biotechnology startups?
OmniBRx Biotechnologies' latest round of $3.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's OmniBRx Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OmniBRx Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.